Login / Signup

Placebo response in RCT for antidepressant may not always be the 'villain' to fight: are KOR antagonists possibly affecting the intrinsic placebo response?

Emilio Merlo Pich
Published in: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2024)
Keyphrases
  • major depressive disorder
  • double blind
  • phase iii
  • randomized controlled trial
  • clinical trial
  • bipolar disorder